Long-term growth-related safety outcomes of guanfacine extended release in children and adolescents with ADHD

被引:0
|
作者
Huss, M. [1 ]
Dirks, B. [2 ]
Gu, J. [2 ]
Ramos-Quiroga, J. A. [3 ]
机构
[1] Johannes Gutenberg Univ Mainz, Child & Adolescent Psychiat, Mainz, Germany
[2] Shire, Lexington, MA USA
[3] Hosp Valle De Hebron, Dept Psychiat CIBERSAM, Barcelona, Spain
关键词
HYDROCHLORIDE;
D O I
10.1016/S0924-977X(16)31889-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P.7.d.012
引用
收藏
页码:S735 / S736
页数:2
相关论文
共 50 条
  • [31] Cardiovascular safety of dexmethylphenidate extended release in children with ADHD
    Greenbaum, M.
    Muniz, R.
    Brams, M.
    Boellner, S.
    Gerstner, O.
    Borello, M.
    Thulasiraman, A.
    Post, A.
    ANNALS OF NEUROLOGY, 2007, 62 : S146 - S146
  • [32] Safety and Effectiveness of Coadministration of Guanfacine Extended Release and Psychostimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Spencer, Thomas J.
    Greenbaum, Michael
    Ginsberg, Lawrence D.
    Murphy, William Rory
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (05) : 501 - 510
  • [33] EFFICACY OF LONG-TERM TREATMENT WITH VILOXAZINE EXTENDED-RELEASE CAPSULES (QELBREE™) IN CHILDREN AND ADOLESCENTS WITH ADHD: AN OPEN-LABEL EXTENSION STUDY
    Nasser, Azmi
    Hull, Joseph
    Chaturvedi, Soumya
    Maldonado-Cruz, Zulane
    Liranso, Tesfaye
    Qin, Peibing
    Busse, Gregory
    Rubin, Jonathan
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2021, 60 (10): : S258 - S258
  • [34] Long-Term Safety and Tolerability of Ziprasidone in Children and Adolescents
    Findling, Robert L.
    DelBello, Melissa P.
    Wang, Paul. P.
    Bachinsky, Mary
    Gundapaneni, Balarama
    Versavel, Mark
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (06) : 639 - 639
  • [35] GUANFACINE EXTENDED RELEASE IN THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN CHILDREN AND ADOLESCENTS
    Connor, D. F.
    Rubin, J.
    DRUGS OF TODAY, 2010, 46 (05) : 299 - 314
  • [36] Long-term medication for ADHD and development of cognitive functions in children and adolescents
    Johnson, Mats
    Johnels, Jakob Asberg
    Ostlund, Sven
    Cedergren, Katarina
    Omanovic, Zerina
    Hjalmarsson, Kerstin
    Jakobsson, Klara
    Hogstedt, Jenny
    Billstedt, Eva
    JOURNAL OF PSYCHIATRIC RESEARCH, 2021, 142 : 204 - 209
  • [37] Long-term outcomes for children and adolescents with Kaposi sarcoma
    Silverstein, Allison
    Kamiyango, William
    Villiera, Jimmy
    Peckham-Gregory, Erin C.
    McAtee, Casey L.
    Scheurer, Michael E.
    Cox, Carrie M.
    Kovarik, Carrie L.
    Campbell, Liane R.
    Allen, Carl E.
    Mehta, Parth S.
    Kazembe, Peter N.
    Ozuah, Nmazuo W.
    El-Mallawany, Nader Kim
    HIV MEDICINE, 2022, 23 (02) : 197 - 203
  • [38] Long-Term Cardiovascular Outcomes in Children and Adolescents With Hypertension
    Robinson, Cal H.
    Hussain, Junayd
    Jeyakumar, Nivethika
    Smith, Graham
    Birken, Catherine S.
    Dart, Allison
    Dionne, Janis
    Garg, Anika
    Kandasamy, Sujane
    Karam, Sabine
    Marjerrison, Stacey
    South, Andrew M.
    Thabane, Lehana
    Wahi, Gita
    Zappitelli, Michael
    Chanchlani, Rahul
    JAMA PEDIATRICS, 2024, 178 (07) : 688 - 698
  • [39] Long-term outcomes of pulmonary embolism in children and adolescents
    Bastas, Denise
    Brandao, Leonardo R.
    Vincelli, Jennifer
    Wilson, David
    Perrem, Lucy
    Guerra, Vitor
    Wong, Gina
    Bentley, Robert F.
    Tole, Soumitra
    Schneiderman, Jane E.
    Amiri, Nour
    Williams, Suzan
    Avila, M. Laura
    BLOOD, 2024, 143 (07) : 631 - 640
  • [40] Long-Term Kidney Outcomes in Children and Adolescents with Hypertension
    Robinson, Cal
    Hussain, Junayd
    Brady, Tammy McLoughlin
    Dionne, Janis M.
    Karam, Sabine
    McKay, Ashlene Maree
    Shroff, Rukshana
    Chanchlani, Rahul
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):